340b | News
15484
paged,page,page-id-15484,page-template,page-template-blog-large-image,page-template-blog-large-image-php,paged-7,page-paged-7,ajax_fade,page_not_loaded,,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

25 Aug Slate: Good Lord. Even the Price of Insulin Is Skyrocketing.

At this point, it’s getting hard to keep track of all the stories of drug companies jacking up the prices of prescription medications to nauseating heights for little identifiable reason other than the fact that, unlike in other developed countries, the U.S. government lets them....

Read More

29 Jun Why 340B Matters to South Dakota

table, th, td { border: 1px solid black; } Why 340B Matters to South Dakota Local Hospitals Could Lose Millions in Savings “Our hospital, patients and community depend on the 340B program. It has a proven track record of expanding access to medical services for some of...

Read More

19 May The Hill: Serving the poor is what we do

Every day, the 340B drug discount program helps providers that treat the underserved across America and it’s more essential than ever. Yet the pharmaceutical industry has attacked hospitals for somehow failing to use it to care for the poor and vulnerable. New data show just...

Read More

19 May The Hill: When drug prices threaten patient care

The debate over high drug prices has raged for decades, thanks to the inherent tension between delivering innovative and cost-effective patient care. But recently something has changed, and it’s one that may have major ramifications for how we take care of patients– hyperinflation in drug...

Read More